Hyundai Bioscience Co., Ltd. (KOSDAQ:048410)
South Korea · Delayed Price · Currency is KRW 6,390.00
-190.00 (-2.89%)
Sep 1, 2026, 3:30 PM KST
Hyundai Bioscience Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -28,609 | -22,128 | -6,930 | -14,499 | -15,807 | -20,051 |
Depreciation & Amortization | 1,412 | 1,306 | 633.82 | 1,435 | 1,782 | 2,703 |
Asset Writedown & Restructuring Costs | - | - | - | 4,769 | - | 7,517 |
Loss (Gain) From Sale of Investments | 123.04 | 9.04 | -14.05 | -123.67 | -910.99 | - |
Loss (Gain) on Equity Investments | 4,914 | 4,766 | 5,730 | - | -8,834 | -93.91 |
Stock-Based Compensation | 886.15 | 22.6 | -77.98 | 402.42 | 596.94 | 578.26 |
Provision & Write-off of Bad Debts | -28.03 | 89.74 | 156.13 | -28.78 | 5,260 | -583.99 |
Other Operating Activities | 3,911 | 673.67 | 2,717 | 911.44 | -79.49 | 3,925 |
Change in Accounts Receivable | -362.61 | -2,170 | 43.52 | 864.23 | 1,184 | 3,526 |
Change in Inventory | 790.6 | -161.99 | 1,374 | 358.12 | 403.6 | 864.9 |
Change in Accounts Payable | 99.58 | -57.7 | 447.9 | -256.2 | 503.57 | 13.43 |
Change in Other Net Operating Assets | 359.19 | 601.48 | -1,824 | 159.77 | -642.06 | 1,063 |
Operating Cash Flow | -16,503 | -17,050 | 2,257 | -6,008 | -16,544 | -538.48 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -1,013 | -1,194 | -169.57 | -539.7 | -1,544 | -3,747 |
Sale (Purchase) of Intangibles | - | -19,000 | -2,000 | -47.84 | - | -15.12 |
Investment in Securities | -2,661 | -19,836 | -16,934 | 6,000 | 10,210 | -13,010 |
Other Investing Activities | 1,128 | 1,233 | -773.14 | -557 | -0.4 | 1,773 |
Investing Cash Flow | -2,364 | -38,586 | -19,740 | 5,177 | 8,518 | -12,359 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 14,845 | 20,001 | - | - | - |
Total Debt Issued | 24,843 | 14,845 | 20,001 | - | - | - |
Short-Term Debt Repaid | - | -5,000 | -400 | -500 | -500 | - |
Long-Term Debt Repaid | - | -19,386 | -116.58 | -362.88 | -1,194 | -1,246 |
Total Debt Repaid | -426.74 | -24,386 | -516.58 | -862.88 | -1,694 | -1,246 |
Net Debt Issued (Repaid) | 24,416 | -9,541 | 19,484 | -862.88 | -1,694 | -1,246 |
Issuance of Common Stock | - | 84,258 | 139.96 | 1,094 | 3,596 | 4,449 |
Other Financing Activities | -151.56 | -344.38 | -434.78 | -289.18 | -229.04 | -209.66 |
Financing Cash Flow | 24,264 | 74,373 | 19,190 | -57.97 | 1,673 | 2,994 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 107 | -56.06 | 138.47 | -31.72 | -103.42 | -122.29 |
Miscellaneous Cash Flow Adjustments | - | -0 | 0 | - | - | - |
Net Cash Flow | 5,505 | 18,681 | 1,845 | -920.54 | -6,456 | -10,026 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -17,516 | -18,244 | 2,087 | -6,548 | -18,087 | -4,285 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -527.47% | -518.69% | 13.87% | -69.06% | -230.36% | -46.37% |
Free Cash Flow Per Share | -182.25 | -194.05 | 26.21 | -82.31 | -229.72 | -58.04 |
Levered Free Cash Flow | -9,165 | -31,915 | -2,581 | -4,900 | -8,388 | 1,337 |
Unlevered Free Cash Flow | -8,098 | -30,393 | -1,135 | -4,704 | -8,108 | 3,214 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 149.08 | 344.38 | 434.78 | 289.18 | 222.4 | 209.66 |
Cash Income Tax Paid | 1,841 | 136.58 | -54.28 | 19.19 | -17.99 | 78.92 |
Change in Working Capital | 886.76 | -1,788 | 41.17 | 1,126 | 1,449 | 5,467 |